Literature DB >> 22251566

Cannabinoid receptor signaling and modulation of monoamines: implications for psychiatric and neurological disorders.

Elisabeth J Van Bockstaele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22251566      PMCID： PMC4707950          DOI： 10.1016/j.pnpbp.2012.01.002

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN： 0278-5846            Impact factor:   5.067


× No keyword cloud information.
  26 in total

Review 1.  The endocannabinoid system: a drug discovery perspective.

Authors:  Daniele Piomelli
Journal:  Curr Opin Investig Drugs       Date:  2005-07

Review 2.  The biosynthesis, fate and pharmacological properties of endocannabinoids.

Authors:  V Di Marzo; L De Petrocellis; T Bisogno
Journal:  Handb Exp Pharmacol       Date:  2005

Review 3.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 4.  Endogenous cannabinoid signaling.

Authors:  D Piomelli; M Beltramo; A Giuffrida; N Stella
Journal:  Neurobiol Dis       Date:  1998-12       Impact factor: 5.996

5.  Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.

Authors:  G Gobbi; F R Bambico; R Mangieri; M Bortolato; P Campolongo; M Solinas; T Cassano; M G Morgese; G Debonnel; A Duranti; A Tontini; G Tarzia; M Mor; V Trezza; S R Goldberg; V Cuomo; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

Review 6.  Monoamine receptor systems and anxiety disorders.

Authors:  G R Heninger; D S Charney
Journal:  Psychiatr Clin North Am       Date:  1988-06

7.  Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder.

Authors:  D S Charney; S W Woods; G R Heninger
Journal:  Psychiatry Res       Date:  1989-02       Impact factor: 3.222

8.  Anxiety and Depression: Optimizing Treatments.

Authors:  James C. Ballenger
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-06

Review 9.  Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis.

Authors:  David R Janero; Alexandros Makriyannis
Journal:  Expert Opin Emerg Drugs       Date:  2009-03       Impact factor: 4.191

Review 10.  Pleiotropic effects of rimonabant: clinical implications.

Authors:  Jean-Pierre Després
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116
View more
  3 in total

1.  Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats.

Authors:  Philippe De Deurwaerdère; Maurizio Casarrubea; Daniel Cassar; Manuela Radic; Emilie Puginier; Abdeslam Chagraoui; Giuseppe Crescimanno; Vincenzo Crunelli; Giuseppe Di Giovanni
Journal:  Front Cell Neurosci       Date:  2022-05-23       Impact factor: 6.147

2.  Noradrenergic depletion causes sex specific alterations in the endocannabinoid system in the Murine prefrontal cortex.

Authors:  M A Urquhart; J A Ross; B A S Reyes; M Nitikman; S A Thomas; K Mackie; E J Van Bockstaele
Journal:  Neurobiol Stress       Date:  2019-04-10

3.  The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area.

Authors:  Hong Zhang; Austin A Lipinski; Erika Liktor-Busa; Angela F Smith; Aubin Moutal; Rajesh Khanna; Paul R Langlais; Tally M Largent-Milnes; Todd W Vanderah
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.